Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 1863 entries
View as:

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02280356 Org: User:
Start: 10/28/14 End: 01/09/23 Due: 01/09/24

Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT02282371 Org: User:
Start: 10/30/14 End: 10/22/21 Due: 10/22/22

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Phase: N/A Priority: Normal
NCT ID: NCT03572374 Org: User:
Start: 06/07/18 End: 06/30/26 Due: 06/30/27

Iomab-ACT: a Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04512716 Org: User:
Start: 02/02/21 End: 01/31/26 Due: 01/31/27

Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00917462 Org: User:
Start: 06/30/09 End: 08/31/18 Due: 08/31/19

Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00492167 Org: User:
Start: 09/09/05 End: 03/04/22 Due: 03/04/23

Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

Phase: N/A Priority: Normal
NCT ID: NCT03615105 Org: User:
Start: 07/25/18 End: 03/06/24 Due: 03/06/25

Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00016146 Org: User:
Start: 07/31/00 End: 03/31/09 Due: 03/31/10

Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00049101 Org: User:
Start: 08/31/02 End: 08/31/04 Due: 08/31/05

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04635735 Org: User:
Start: 01/12/20 End: 02/02/23 Due: 02/02/24

Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00588263 Org: User:
Start: 07/31/00 End: 07/31/18 Due: 07/31/19

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02312401 Org: User:
Start: 12/31/14 End: 12/31/25 Due: 12/31/26

Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

Phase: N/A Priority: Normal
NCT ID: NCT01596283 Org: User:
Start: 04/30/12 End: 05/31/16 Due: 05/31/17

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Phase: N/A Priority: Normal
NCT ID: NCT01392222 Org: User:
Start: 06/30/11 End: 06/30/17 Due: 06/30/18

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00974818 Org: User:
Start: 09/30/09 End: 03/31/12 Due: 03/31/13

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00416351 Org: User:
Start: 06/27/06 End: 03/01/21 Due: 03/01/22

A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone

Phase: N/A Priority: Normal
NCT ID: NCT05038124 Org: User:
Start: 06/30/21 End: 06/30/26 Due: 06/30/27

A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06240598 Org: User:
Start: 01/26/24 End: 01/31/26 Due: 01/31/27

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03015129 Org: User:
Start: 01/31/17 End: 12/30/22 Due: 12/30/23

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04454450 Org: User:
Start: 06/22/20 End: 06/30/26 Due: 06/30/27

Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT02371135 Org: User:
Start: 02/28/15 End: 02/28/26 Due: 02/28/27

Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04107285 Org: User:
Start: 09/25/19 End: 09/30/25 Due: 09/30/26

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

Phase: N/A Priority: Normal
NCT ID: NCT02507141 Org: User:
Start: 07/21/15 End: 07/31/26 Due: 07/31/27

Genomic Profiling in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01775072 Org: User:
Start: 01/31/13 End: 01/31/26 Due: 01/31/27

Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00458705 Org: User:
Start: 11/30/06 End: 04/30/11 Due: 04/30/12